Madrigal Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$518.76(as of Mar 26, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Madrigal Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$518.76
Ticker SymbolMDGL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees915
CountyUSA
Market Cap$10,596.7M
EBIDTA-298.6M
10-Day Moving Average453.97
P/E Ratio-40.37
20-Day Moving Average443.82
Forward P/E Ratio666.67
50-Day Moving Average464.55
Earnings per Share-12.84
200-Day Moving Average441.10
Profit Margin-18.24%
RSI71.85
Shares Outstanding22.9M
ATR25.92
52-Week High615.00
Volume1,344,773
52-Week Low265.00
Book Value602.7M
P/B Ratio19.31
Upper Keltner502.15
P/S Ratio12.14
Lower Keltner385.49
Debt-to-Equity Ratio502.15
Next Earnings Date05/12/2026
Cash Surplus-111.6M
Next Ex-Dividend DateUnknown
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Madrigal Pharmaceuticals Inc In Our Stock Scanner
As of Mar 27, 2026
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.